A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

Clinical trial NCT07021898 · RECRUITING

Trial details

NCT number: NCT07021898
Sponsor: Erasca, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Solid Tumors

Start date: 2025-08-06
Primary completion: 2028-08-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.